FR09C0022I2 - - Google Patents

Info

Publication number
FR09C0022I2
FR09C0022I2 FR09C0022C FR09C0022C FR09C0022I2 FR 09C0022 I2 FR09C0022 I2 FR 09C0022I2 FR 09C0022 C FR09C0022 C FR 09C0022C FR 09C0022 C FR09C0022 C FR 09C0022C FR 09C0022 I2 FR09C0022 I2 FR 09C0022I2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR09C0022C
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of FR09C0022I1 publication Critical patent/FR09C0022I1/fr
Application granted granted Critical
Publication of FR09C0022I2 publication Critical patent/FR09C0022I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
FR09C0022C 1996-12-11 2009-05-25 Active FR09C0022I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3282096P 1996-12-11 1996-12-11
US08/886,933 US6071904A (en) 1996-12-11 1997-07-02 Process for manufacturing ophthalmic suspensions
PCT/US1997/015727 WO1998025620A1 (fr) 1996-12-11 1997-09-05 Procede de fabrication de suspensions ophtalmiques

Publications (2)

Publication Number Publication Date
FR09C0022I1 FR09C0022I1 (fr) 2009-09-25
FR09C0022I2 true FR09C0022I2 (fr) 2010-06-11

Family

ID=26708929

Family Applications (1)

Application Number Title Priority Date Filing Date
FR09C0022C Active FR09C0022I2 (fr) 1996-12-11 2009-05-25

Country Status (14)

Country Link
US (1) US6071904A (fr)
EP (1) EP0941094B1 (fr)
JP (1) JP3611863B2 (fr)
AT (1) ATE209917T1 (fr)
CA (1) CA2274680C (fr)
DE (2) DE69708912T2 (fr)
DK (1) DK0941094T3 (fr)
ES (1) ES2169416T3 (fr)
FR (1) FR09C0022I2 (fr)
HK (1) HK1019704A1 (fr)
LU (1) LU91554I2 (fr)
NL (1) NL300388I2 (fr)
PT (1) PT941094E (fr)
WO (1) WO1998025620A1 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001365A1 (fr) * 1998-06-30 2000-01-13 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Compositions ophtalmiques a liberation prolongee contenant une fluoroquinolone
CN1509462A (zh) 2001-05-21 2004-06-30 NF-κB抑制剂在治疗干眼疾病中的用途
EP1392322A1 (fr) * 2001-05-21 2004-03-03 Alcon, Inc. Methode traitement de la secheresse oculaire
PT1392355E (pt) 2001-05-21 2007-03-30 Alcon Inc Utilização de inibidores do proteassoma para tratar distúrbios associados à secura ocular
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
US7112588B2 (en) * 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
JP2005523295A (ja) * 2002-03-01 2005-08-04 ノバガリ、ファルマ、エスアー 難溶性薬剤の自己乳化型薬物送達システム
CN100341498C (zh) 2003-01-21 2007-10-10 千寿制药株式会社 含有2－氨基－3－(4－溴苯甲酰基)苯乙酸的水成液制剂
US7892483B2 (en) * 2004-03-12 2011-02-22 Cipla Limited Sterilization process
PT1891939E (pt) * 2006-07-28 2013-10-07 Novagali Pharma Sa Composições contendo compostos de amónio quaternário
WO2008035246A2 (fr) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions contenant des composés ammonium quaternaire
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
TWI489997B (zh) * 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
EP2506878A2 (fr) 2009-12-03 2012-10-10 Lupin Limited Procede d'elaboration de compositions ophtalmiques pharmaceutiques
EP2394637A1 (fr) * 2010-05-21 2011-12-14 Zaklady Farmaceutyczne Polpharma SA Procédé pour l'obtention de suspensions stériles de brinzolamide
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
CA2807081C (fr) 2010-07-29 2018-09-18 Allergan, Inc. Solutions de bimatoprost et de timolol sans conservateur
WO2012053011A2 (fr) 2010-10-18 2012-04-26 Usv Limited Compositions ophthalmiques comprenant de la brinzolamide
US20130065888A1 (en) 2011-08-15 2013-03-14 Biserka Cetina-Cizmek Ophthalmic formulations and processes for their preparation
EP2638909A1 (fr) 2012-03-15 2013-09-18 Azad Pharmaceutical Ingredients AG Procédé de préparation stérile brinzolamide
GR1007906B (el) * 2012-03-22 2013-05-30 Φαρματεν Αβεε, Οφθαλμικο φαρμακευτικο σκευασμα περιεχον ενα αναστολεα καρβονικης ανυδρασης και μεθοδος για την παρασκευη αυτου
PT2846845T (pt) 2012-05-09 2017-06-02 Icrom Spa Produção de brinzolamida farmacêutica estéril
WO2013175285A1 (fr) 2012-05-21 2013-11-28 Aurobindo Pharma Limited Procédé de préparation d'une suspension ophtalmique de brinzolamide
WO2014057499A1 (fr) 2012-10-11 2014-04-17 Indoco Remedies Limited Procédé de production d'une suspension ophtalmique stérile à base de la brinzolamide
CN104721136A (zh) * 2013-02-21 2015-06-24 四川大学 一种布佐林胺眼用纳米混悬剂及其制备方法
EA030535B1 (ru) * 2013-10-17 2018-08-31 Сентисс Фарма Прайвет Лимитед Не содержащий консерванта офтальмологический фармацевтический состав
WO2015068105A1 (fr) 2013-11-08 2015-05-14 Sentiss Pharma Private Limited Procédé amélioré de fabrication de suspensions pharmaceutiques ophtalmiques stériles
US9820991B2 (en) * 2013-11-08 2017-11-21 Sentiss Pharma Private Limited Pharmaceutical composition comprising brinzolamide
UA118576C2 (uk) * 2014-01-24 2019-02-11 Сентис Фарма Прайвет Лімітед Фармацевтична композиція, яка містить бринзоламід
PL407710A1 (pl) 2014-03-28 2015-10-12 Instytut Farmaceutyczny Sposób wytwarzania preparatu kropli do oczu w postaci zawiesiny zawierającej brynzolamid i preparat wytworzony tym sposobem
JP6279395B2 (ja) * 2014-05-01 2018-02-14 東亜薬品株式会社 ブリンゾラミド懸濁性点眼液組成物の製造方法
WO2016063184A1 (fr) 2014-10-20 2016-04-28 Sentiss Pharma Private Limited Solution ophtalmique
TWI664965B (zh) * 2015-06-22 2019-07-11 新源生物科技股份有限公司 酪胺酸激酶抑制劑之眼用調配物、其使用方法、及其製備方法
CN107582519A (zh) * 2017-06-01 2018-01-16 合肥远志医药科技开发有限公司 一种布林佐胺滴眼液制剂及其制备方法
GR1009419B (el) 2017-11-07 2018-12-14 Φαρματεν Αβεε Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου
WO2019207380A1 (fr) 2018-04-25 2019-10-31 Shilpa Medicare Limited Compositions ophtalmiques de brinzolamide
GR1009616B (el) * 2018-07-20 2019-10-11 Φαρματεν Α.Β.Ε.Ε. Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει βρινζολαμιδη και τιμολολη και μεθοδος παρασκευης αυτου
MX2021014477A (es) 2019-05-29 2022-01-06 Lupin Ltd Nanoemulsion gelificante in situ de brinzolamida.
US20220105101A1 (en) * 2020-10-05 2022-04-07 Somerset Therapeutics, Llc Efficient brinzolamide and brimonidine compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
WO1992018124A1 (fr) * 1991-04-17 1992-10-29 Merck & Co., Inc. COMPOSITIONS OPHTALMIQUES RENFERMANT DES COMBINAISONS D'UN INHIBITEUR D'ANHYDRASE CARBONIQUE ET D'UN ANTAGONISTE β-ADRENERGIQUE
AU677577B2 (en) * 1992-02-21 1997-05-01 Alcon Laboratories, Inc. Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
US5346702A (en) * 1992-12-04 1994-09-13 Sterling Winthrop Inc. Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
US5429824A (en) * 1992-12-15 1995-07-04 Eastman Kodak Company Use of tyloxapole as a nanoparticle stabilizer and dispersant
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system

Also Published As

Publication number Publication date
DE69708912T2 (de) 2002-04-11
EP0941094B1 (fr) 2001-12-05
DE122009000016I1 (de) 2009-06-25
HK1019704A1 (en) 2000-02-25
LU91554I2 (fr) 2009-06-22
CA2274680C (fr) 2003-11-18
CA2274680A1 (fr) 1998-06-18
US6071904A (en) 2000-06-06
PT941094E (pt) 2002-05-31
ES2169416T3 (es) 2002-07-01
JP2000501749A (ja) 2000-02-15
ATE209917T1 (de) 2001-12-15
EP0941094A1 (fr) 1999-09-15
NL300388I1 (nl) 2009-07-01
JP3611863B2 (ja) 2005-01-19
FR09C0022I1 (fr) 2009-09-25
DK0941094T3 (da) 2002-01-07
AU4183897A (en) 1998-07-03
AU718079B2 (en) 2000-04-06
WO1998025620A1 (fr) 1998-06-18
DE69708912D1 (de) 2002-01-17
NL300388I2 (nl) 2010-02-01

Similar Documents

Publication Publication Date Title
AR026661A2 (fr)
BRPI9713914B8 (fr)
FR09C0022I1 (fr)
ITMI960356A0 (fr)
BR7600721U (fr)
BR7601346U (fr)
BR9603859A (fr)
ITMI960262A0 (fr)
ITMI960198A0 (fr)
CN3045530S (fr)
CN3046158S (fr)
CN3041207S (fr)
CN3040543S (fr)
CN3041383S (fr)
CN3042289S (fr)
CN3043305S (fr)
CN3044168S (fr)
CN3044346S (fr)
CN3044347S (fr)
CN3044348S (fr)
CN3044349S (fr)
CN3045208S (fr)
CN3040367S (fr)
CN3045806S (fr)
CN3039213S (fr)